406 related articles for article (PubMed ID: 11747345)
1. Selective modulation of P-glycoprotein-mediated drug resistance.
Bebawy M; Morris MB; Roufogalis BD
Br J Cancer; 2001 Dec; 85(12):1998-2003. PubMed ID: 11747345
[TBL] [Abstract][Full Text] [Related]
2. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype.
Mi Q; Cui B; Silva GL; Lantvit D; Lim E; Chai H; You M; Hollingshead MG; Mayo JG; Kinghorn AD; Pezzuto JM
Cancer Res; 2001 May; 61(10):4030-7. PubMed ID: 11358822
[TBL] [Abstract][Full Text] [Related]
3. A continuous fluorescence assay for the study of P-glycoprotein-mediated drug efflux using inside-out membrane vesicles.
Bebawy M; Morris MB; Roufogalis BD
Anal Biochem; 1999 Mar; 268(2):270-7. PubMed ID: 10075817
[TBL] [Abstract][Full Text] [Related]
4. Direct interaction between verapamil and doxorubicin causes the lack of reversal effect of verapamil on P-glycoprotein mediated resistance to doxorubicin in vitro using L1210/VCR cells.
Breier A; Drobná Z; Barancík M
Neoplasma; 1998; 45(4):248-53. PubMed ID: 9890669
[TBL] [Abstract][Full Text] [Related]
5. Mode of action of torilin in multidrug-resistant cancer cell lines.
Kim SE; Hong YS; Kim YC; Lee JJ
Planta Med; 1998 May; 64(4):335-8. PubMed ID: 9619116
[TBL] [Abstract][Full Text] [Related]
6. Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells.
Gayet L; Dayan G; Barakat S; Labialle S; Michaud M; Cogne S; Mazane A; Coleman AW; Rigal D; Baggetto LG
Biochemistry; 2005 Mar; 44(11):4499-509. PubMed ID: 15766280
[TBL] [Abstract][Full Text] [Related]
7. Effects of vinblastine, colchicine, and verapamil on rhodamine 123 accumulation in human P-glycoprotein-positive leukemia cells.
Lautier D; Canitrot Y; Salmon JM
Anticancer Res; 1994; 14(6B):2589-95. PubMed ID: 7872686
[TBL] [Abstract][Full Text] [Related]
8. Reversal of P-glycoprotein-mediated multidrug resistance by cholesterol derived from low density lipoprotein in a vinblastine-resistant human lymphoblastic leukemia cell line.
Shu Y; Liu H
Biochem Cell Biol; 2007 Oct; 85(5):638-46. PubMed ID: 17901905
[TBL] [Abstract][Full Text] [Related]
9. Reversal of vinblastine transport by chlorpromazine in membrane vesicles from multidrug-resistant human CCRF-CEM leukaemia cells.
Syed SK; Christopherson RI; Roufogalis BD
Br J Cancer; 1998 Aug; 78(3):321-7. PubMed ID: 9703277
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells.
Lavie Y; Harel-Orbital T; Gaffield W; Liscovitch M
Anticancer Res; 2001; 21(2A):1189-94. PubMed ID: 11396162
[TBL] [Abstract][Full Text] [Related]
11. Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substrates.
Stein WD; Cardarelli C; Pastan I; Gottesman MM
Mol Pharmacol; 1994 Apr; 45(4):763-72. PubMed ID: 7910372
[TBL] [Abstract][Full Text] [Related]
12. Drugs transported by P-glycoprotein inhibit a 40 pS outwardly rectifying chloride channel.
Bear CE
Biochem Biophys Res Commun; 1994 Apr; 200(1):513-21. PubMed ID: 7909435
[TBL] [Abstract][Full Text] [Related]
13. Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensitizers.
Abbaszadegan MR; Cress AE; Futscher BW; Bellamy WT; Dalton WS
Cancer Res; 1996 Dec; 56(23):5435-42. PubMed ID: 8968098
[TBL] [Abstract][Full Text] [Related]
14. Secretion of lysosomal enzymes by drug-sensitive and multiple drug-resistant cells.
Warren L; Jardillier JC; Ordentlich P
Cancer Res; 1991 Apr; 51(8):1996-2001. PubMed ID: 1672622
[TBL] [Abstract][Full Text] [Related]
15. Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid.
Majumder S; Dutta P; Mukherjee P; Datta ER; Efferth T; Bhattacharya S; Choudhuri SK
Cancer Lett; 2006 Nov; 244(1):16-23. PubMed ID: 16410038
[TBL] [Abstract][Full Text] [Related]
16. Characterization of 2-chloro-N10-substituted phenoxazines for reversing multidrug resistance in cancer cells.
Thimmaiah KN; Jayashree BS; Germain GS; Houghton PJ; Horton JK
Oncol Res; 1998; 10(1):29-41. PubMed ID: 9613455
[TBL] [Abstract][Full Text] [Related]
17. Modulation of cancer cell multidrug resistance by an extract of Ficus citrifolia.
Simon PN; Chaboud A; Darbour N; Di Pietro A; Dumontet C; Lurel F; Raynaud J; Barron D
Anticancer Res; 2001; 21(2A):1023-7. PubMed ID: 11396135
[TBL] [Abstract][Full Text] [Related]
18. A flow cell assay for evaluation of whole cell drug efflux kinetics: analysis of paclitaxel efflux in CCRF-CEM leukemia cells overexpressing P-glycoprotein.
Lin JT; Sharma R; Grady JJ; Awasthi S
Drug Metab Dispos; 2001 Feb; 29(2):103-10. PubMed ID: 11159798
[TBL] [Abstract][Full Text] [Related]
19. Specific reversal of multidrug resistance to colchicine in CEM/VLB(100) cells by Gynostemma pentaphyllum extract.
Huang TH; Bebawy M; Tran VH; Roufogalis BD
Phytomedicine; 2007 Dec; 14(12):830-9. PubMed ID: 17950589
[TBL] [Abstract][Full Text] [Related]
20. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
Taub ME; Podila L; Ely D; Almeida I
Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
